Provided by Tiger Trade Technology Pte. Ltd.

Beam Therapeutics, Inc.

25.18
-1.6550-6.17%
Pre-market: 25.600.4250+1.69%07:42 EDT
Volume:2.85M
Turnover:72.77M
Market Cap:2.60B
PE:-30.06
High:26.70
Open:26.70
Low:25.11
Close:26.83
52wk High:38.26
52wk Low:19.57
Shares:103.29M
Float Shares:91.60M
Volume Ratio:1.32
T/O Rate:3.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8376
EPS(LYR):-0.8100
ROE:-8.18%
ROA:-17.01%
PB:2.44
PE(LYR):-31.08

Loading ...

Cathie Wood’s ARK Investment buys 271K shares of Beam Therapeutics today

TIPRANKS
·
11 hours ago

Wedbush Reaffirms Their Buy Rating on Beam Therapeutics (BEAM)

TIPRANKS
·
Yesterday

JonesTrading Remains a Buy on Beam Therapeutics (BEAM)

TIPRANKS
·
Yesterday

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

TIPRANKS
·
Yesterday

Shares of Beam Therapeutics Retreat After Updated Trial Data Disappoints

Dow Jones
·
Yesterday

Beam Therapeutics falls -12.7%

TIPRANKS
·
Sep 08

Beam Therapeutics’ BEAM-302 shows efficacy in Phase 1/2 AATD trial

TIPRANKS
·
Sep 08

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of Beam-302 in Alpha-1 Antitrypsin Deficiency (Aatd) at the European Respiratory Society (Ers) Congress 2026

THOMSON REUTERS
·
Sep 08

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

GlobeNewswire
·
Sep 08

Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips

AI Industry Frontlines
·
Sep 08

Press Release: Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer

Dow Jones
·
Sep 01

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), OmniAb (OABI) and Astrana Health (ASTH)

TIPRANKS
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Ultragenyx Pharmaceutical (RARE) and Beam Therapeutics (BEAM)

TIPRANKS
·
Aug 05

Evercore ISI Reaffirms Their Buy Rating on Beam Therapeutics (BEAM)

TIPRANKS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Waters (WAT), Beam Therapeutics (BEAM) and Green Thumb Industries (OtherGTBIF)

TIPRANKS
·
Aug 05

Clear Street Remains a Buy on Beam Therapeutics (BEAM)

TIPRANKS
·
Aug 05

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 05

Beam Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Earnings Flash (BEAM) Beam Therapeutics Posts Q2 Loss $1.18 a Share, vs. FactSet Est of $1.11 Loss

MT Newswires Live
·
Aug 04

Beam Therapeutics Q2 Operating Expenses USD 127.043 Million

THOMSON REUTERS
·
Aug 04